SCIENTIFIC STUDIES CARDIOVASCULAR REVASCULARIZATION MEDICINE   including Molecular Interventions Posted January 1, 2008   CLICK HERE TO DOWNLOAD SUMMARY     Abstract - PubMed.gov   Description Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine. Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management, and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, congenital heart disease, coronary heart disease, epidemiology, genetics, health services and outcomes research, invasive imaging, molecular cardiology, preventive cardiology, and vascular medicine. Cardiovascular Revascularization Medicine will consider all articles describing clinical trials and translational research (ie, those that unite the clinic with the laboratory). The Journal publishes original articles, rapid communications, reviews, technical notes, teaching editorials, and special features. Original articles that address any aspect of cardiovascular revascularization medicine are invited. Letters to the Editor and interesting images are encouraged.   STUDY:  StemEnhance® improves physical performance of weight training in non-professional participants STUDY:  Muscle Injury                                Published: HealthSPAN Canada, Fall 2008, p5 VIEW THE PATENT